AMPE | Hard Not To See Potential In Ampio Pharmaceuticals

AMPE stock, Ampio Pharmaceuticals, ZertaneShares of Ampio Pharmaceuticals Inc. (AMPE) are not having their best trading after analysts at Aegis set a “buy” rating and a $11.00 price target on the stock. Having seen $8.50 well back in October of last year, AMPE stock is not having the rally a biopharmaceutical company should have after being upgraded and agreeing with ...

Continue Reading →